* Newstin.co.uk is for sale! * After achieving our strategic milestone, we are offering for sale: Newstin.co.uk and all 14 related domains featuring 1 million unique visitors per month + continuously updated news database of 37 million articles in 12 world languages from 166,000 global and weighted sources + 2.1 billion metadata * To seize this unique chance, contact invest@newstin.com. * Newstin.co.uk is for sale! *

Hemispherx Biopharma

                   

Hemispherx Engages The Sage Group as Its Corporate Partnership Advisor for Ampligen to Treat...

primenewswire.com
yesterday 3 related
        

PHILADELPHIA, Oct. 6, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (Amex:HEB) today announced that it has engaged The Sage Group to assist Hemispherx to identify, select, negotiate, and close a corporate partnership for...

add comment

Hemispherx to Present Data At 'Second World Conference On Magic Bullets (Erlich II)' (GlobeNewswire)

yahoo.com
30-Sep-2008
        

Tuesday September 30, 9:30 am ET 100th Anniversary of Nobel Prize to Paul Ehrlich PHILADELPHIA, Sept. 30, 2008 (GLOBE NEWSWIRE) -- News ) announced that a member of its Board of Directors, Professor William M. Mitchell, M.D.,...

add comment
                   

InPlay: Sanofi-Aventis says FDA approves nasacort AQ nasal spray for children aged 2-5 years old...

yahoo.com
23-Sep-2008 11 related
        

10:44AM Navigators Group's Navigators Management has increased its capacity for directors and officers liability insurance in response to the recent turmoil involving financial institutions and the capital markets 59.50...

add comment
                   

Hemispherx Biopharma, Inc. Adjourns Stockholder Meeting Due to Lack of a Quorum to October 17, 2008

redorbit.com
17-Sep-2008 2 related
        

PHILADELPHIA, Sept. 17, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that it adjourned its annual stockholders' meeting, held today, to Friday, October 17, 2008 at 10:00 a.m. at the Crown...

add comment
                   

Hemispherx Biopharma to Present At BioPharm America Conference

primenewswire.com
03-Sep-2008
        

PHILADELPHIA, Sept. 3, 2008 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) today announced that the Company will present at the BioPharm America Conference to be held on September 9 to 10, 2008 at the Grand...

add comment
                   

Hemispherx Biopharma, Inc. Releases Financial Results for the

pharmiweb.co.uk
12-Aug-2008 3 related
        

Stocks mentioned in this article PHILADELPHIA, Aug. 12, 2008 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced its financial results for the fiscal quarter ended June 30, 2008. This reduced net loss of...

add comment
                   

Hemispherx Biopharma to Host Investor Conference Call On Chronic Fatigue Syndrome NDA Filing

pharmiweb.co.uk
15-Jul-2008 11 related
        

Tuesday July 15, 9:30 am ET Discussion to Also Address Other Corporate Initiatives PHILADELPHIA, July 15, 2008 (PRIME NEWSWIRE) -- News ) today announced that it has scheduled an investor conference call and webcast to take...

add comment
pharmiweb.co.uk: Weekly Special pharmiweb.co.uk

FDA accepts antiviral drug AmpligenR for review as first-ever ME/CFS ('chronic fatigue syndrome')...

pharmiweb.co.uk
12-Jul-2008
        

July 8 – After 30 years in development and testing, the experimental “antiviral/immune modulatoryâ€_ drug AmpligenR has been accepted by the FDA for review as potentially the first prescription drug approved in the U.S. for...

add comment
                   

Twenty Stocks to Short Sell

istockanalyst.com
09-Jul-2008
        

Just put ‘em all in a watchlist and watch ‘em…some will go nowhere, some will spike, some will drop…aim small, miss small, learn to understand the setups that lead to the biggest drops:GETG had a nice reversal—thought about...

add comment

FDA Accepts Hemispherx's Chronic Fatigue Syndrome Drug For Review

pharmiweb.co.uk
09-Jul-2008 10 related
        

Wednesday, July 09, 2008; Posted: 12:14 AM -- July 9, 2008 (FinancialWire) Shares of Hemispherx Biopharma (AMEX: ) (Current Market Cap: US$76.93 Mil.) spiked after the Food and Drug Administration accepted for review the...

add comment
1 2 3 next